Letter/Comment
The latest advocacy letters and comments from the 黑料正能量 Association.
AHA provides feedback on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress鈥 continued efforts to transform health care through permanent telehealth reform
AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (鈥淧art 2鈥).
January 27, 2023
Emeka Egwim, PharmD, RPh LCDR
U.S. Public Health Service Director
Office of Pharmacy Affairs
Health Resources and Services Administration 5600 Fishers Lane, 08W05A
Rockville, MD 20857
RE: HRSA 340B Drug Pricing Program; Administrative Dispute Resolution Proposed Rule, HHS Docket鈥
AHA Comments on AHRQ鈥檚 Request for Information on Creating a National Health Care System Action Alliance to Advance Patient Safety, Dec. 12, 2022
The AHA appreciates the opportunity to share our comments and asks that commissioners consider the following issues before making their final payment update recommendations.
AHA expresses concern about the potential impact of H.R. 3648, the Equal
Access to Green Cards for Legal Employment (EAGLE) Act of 2022
The 黑料正能量 Association (AHA) writes to provide feedback on the cybersecurity policy proposals released in Senator Mark R. Warner's report last month. Cybersecurity is, at its core, a necessary element of patient safety for hospitals and health systems.
The AHA believes physical and mental health care are inextricably linked, and everyone deserves access to quality behavioral health care. We write to encourage Congress to take steps to provide relief to those seeking and administering behavioral health care.
The 黑料正能量 Association (AHA) appreciates the Medicare Payment Advisory Commission鈥檚 (MedPAC) continued discussions on its safety-net proposal, payment alignment across ambulatory settings and payments to primary care clinicians. As the Commission continues its deliberations, we would鈥
The AHA shares CMS鈥 goals to improve patient access to provider information and to facilitate health information exchange and data reporting. However, we are concerned that adding one more provider directory requirement will not support patients in accessing the information they need about their鈥